Key result
A VE/VCO2 slope ≥45 and peak VO2 <10 mL/kg/min during exercise testing strongly predicted mortality in heart failure patients tested after 2006 (HR 8.2; 95% CI 4.7-14.3; P<.001).
Why the study?
Do cardiopulmonary exercise testing (CPX) parameters (VE/VCO2 slope and peak VO2) maintain their prognostic utility for mortality in heart failure patients over different time periods?
Cohort (n=892)
Do cardiopulmonary exercise testing (CPX) parameters (VE/VCO2 slope and peak VO2) maintain their prognostic utility for mortality in heart failure patients over different time periods?
Hazard Ratio: 8.2 (95% CI 4.7–14.3)
p-value: p=<.001
Cardiopulmonary exercise testing (CPX) parameters, specifically VE/VCO2 slope and peak VO2, remain strong predictors of mortality in heart failure patients in the modern management era.
CPX retains prognostic value across HF management eras; supports ongoing use but leaves open need for contemporary validation.
INTRODUCTION: While the medical management strategy for patients with heart failure (HF) has dramatically changed, cardiopulmonary exercise testing (CPX) procedures and the data obtained have remained relatively stable. We are unaware of any previous investigation that has assessed differences in the prognostic utility of CPX in HF according to time period, reflecting differences in the clinical management of systolic HF. METHODS: Subjects (n = 381) underwent CPX between April 1, 1993, and December 31, 2005, and the remaining 511 were tested between January 1, 2006, and October 28, 2010. Peak oxygen uptake ((Equation is included in full-text article.)O2) and the minute ventilation/carbon dioxide production ((Equation is included in full-text article.)E/(Equation is included in full-text article.)CO2) slope were ascertained for all tests. RESULTS: Both the (Equation is included in full-text article.)E/(Equation is included in full-text article.)CO2 slope and peak (Equation is included in full-text article.)O2 were strong univariate predictors of adverse events in both subgroups. In the multivariate analysis, the (Equation is included in full-text article.)E/(Equation is included in full-text article.)CO2 slope was the strongest predictive marker while peak (Equation is included in full-text article.)O2 added predictive value and was retained in the regression for all scenarios. In subjects undergoing CPX before 2006, a (Equation is included in full-text article.)E/(Equation is included in full-text article.)CO2 slope 45 or greater and a peak (Equation is included in full-text article.)O2 of less than 10 mL · kg · min generated a hazard ratio of 4.2 (95% CI: 1.9-9.1, P < .001) when considering only mortality as an endpoint. In subjects undergoing CPX after 2006, a (Equation is included in full-text article.)E/(Equation is included in full-text article.)CO2 slope 45 or greater and a peak (Equation is included in full-text article.)O2 of less than 10 mL · kg · min generated a hazard ratio of 8.2 (95% CI: 4.7-14.3, P < .001) when considering only mortality as an endpoint. CONCLUSION: The results of this study indicate that CPX continues to be a valuable clinical assessment in the present-day HF management.
No takes yet. Share an insight, caveat, or question.
Arena et al. (2012) conducted a cohort in Heart failure (n=892). Cardiopulmonary exercise testing (VE/VCO2 slope ≥45 and peak VO2 <10 mL/kg/min) vs. Patients without these high-risk CPX parameters was evaluated on Mortality (HR 8.2, 95% CI 4.7-14.3, p=<.001). A VE/VCO2 slope ≥45 and peak VO2 <10 mL/kg/min during exercise testing strongly predicted mortality in heart failure patients tested after 2006 (HR 8.2; 95% CI 4.7-14.3; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: